Cargando…
Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides
A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/ https://www.ncbi.nlm.nih.gov/pubmed/30087309 http://dx.doi.org/10.3390/ijms19082318 |
_version_ | 1783352471959109632 |
---|---|
author | Pospisilova, Sarka Kos, Jiri Michnova, Hana Kapustikova, Iva Strharsky, Tomas Oravec, Michal Moricz, Agnes M. Bakonyi, Jozsef Kauerova, Tereza Kollar, Peter Cizek, Alois Jampilek, Josef |
author_facet | Pospisilova, Sarka Kos, Jiri Michnova, Hana Kapustikova, Iva Strharsky, Tomas Oravec, Michal Moricz, Agnes M. Bakonyi, Jozsef Kauerova, Tereza Kollar, Peter Cizek, Alois Jampilek, Josef |
author_sort | Pospisilova, Sarka |
collection | PubMed |
description | A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC(50) = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed. |
format | Online Article Text |
id | pubmed-6121455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61214552018-09-07 Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides Pospisilova, Sarka Kos, Jiri Michnova, Hana Kapustikova, Iva Strharsky, Tomas Oravec, Michal Moricz, Agnes M. Bakonyi, Jozsef Kauerova, Tereza Kollar, Peter Cizek, Alois Jampilek, Josef Int J Mol Sci Article A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized. Primary in vitro screening of all the synthesized compounds was performed against Staphylococcus aureus, three methicillin-resistant S. aureus strains, Mycobacterium tuberculosis H37Ra, Fusarium avenaceum, and Bipolaris sorokiniana. Several of the tested compounds showed antistaphylococcal, antitubercular, and antifungal activities comparable with or higher than those of ampicillin, isoniazid, and benomyl. (2E)-N-[3,5-bis(trifluoromethyl)phenyl]-3-phenylprop-2-enamide and (2E)-3-phenyl-N-[3-(trifluoromethyl)phenyl]prop-2-enamide showed the highest activities (MICs = 22.27 and 27.47 µM, respectively) against all four staphylococcal strains and against M. tuberculosis. These compounds showed an activity against biofilm formation of S. aureus ATCC 29213 in concentrations close to MICs and an ability to increase the activity of clinically used antibiotics with different mechanisms of action (vancomycin, ciprofloxacin, and tetracycline). In time-kill studies, a decrease of CFU/mL of >99% after 8 h from the beginning of incubation was observed. (2E)-N-(3,5-Dichlorophenyl)- and (2E)-N-(3,4-dichlorophenyl)-3-phenylprop-2-enamide had a MIC = 27.38 µM against M. tuberculosis, while a significant decrease (22.65%) of mycobacterial cell metabolism determined by the MTT assay was observed for the 3,5-dichlorophenyl derivative. (2E)-N-(3-Fluorophenyl)- and (2E)-N-(3-methylphenyl)-3-phenylprop-2-enamide exhibited MICs = 16.58 and 33.71 µM, respectively, against B. sorokiniana. The screening of the cytotoxicity of the most effective antimicrobial compounds was performed using THP-1 cells, and these chosen compounds did not shown any significant lethal effect. The compounds were also evaluated for their activity related to the inhibition of photosynthetic electron transport (PET) in spinach (Spinacia oleracea L.) chloroplasts. (2E)-N-(3,5-dichlorophenyl)-3-phenylprop-2-enamide (IC(50) = 5.1 µM) was the most active PET inhibitor. Compounds with fungicide potency did not show any in vivo toxicity against Nicotiana tabacum var. Samsun. The structure–activity relationships are discussed. MDPI 2018-08-07 /pmc/articles/PMC6121455/ /pubmed/30087309 http://dx.doi.org/10.3390/ijms19082318 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pospisilova, Sarka Kos, Jiri Michnova, Hana Kapustikova, Iva Strharsky, Tomas Oravec, Michal Moricz, Agnes M. Bakonyi, Jozsef Kauerova, Tereza Kollar, Peter Cizek, Alois Jampilek, Josef Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title_full | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title_fullStr | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title_full_unstemmed | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title_short | Synthesis and Spectrum of Biological Activities of Novel N-arylcinnamamides |
title_sort | synthesis and spectrum of biological activities of novel n-arylcinnamamides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121455/ https://www.ncbi.nlm.nih.gov/pubmed/30087309 http://dx.doi.org/10.3390/ijms19082318 |
work_keys_str_mv | AT pospisilovasarka synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT kosjiri synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT michnovahana synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT kapustikovaiva synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT strharskytomas synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT oravecmichal synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT moriczagnesm synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT bakonyijozsef synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT kauerovatereza synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT kollarpeter synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT cizekalois synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides AT jampilekjosef synthesisandspectrumofbiologicalactivitiesofnovelnarylcinnamamides |